Anti-idiotype and anti-immunoglobulin antibodies are promising biomarkers of early breast cancer
|
|
- Silas Snow
- 5 years ago
- Views:
Transcription
1 Anti-idiotype and anti-immunoglobulin antibodies are promising biomarkers of early breast cancer Marie-Claire Maroun, Lawrence Grossman, Rooshan Arshad, Leonard Lipovich, and Félix Fernández Madrid Wayne State University, Detroit, Michigan, USA
2 Disclosures None Supported by NIH R01 CA
3 Just a glimpse Towards a network theory of the immune system 1974
4 Some Grammar in Immunology!
5 The Idiotype Network Theory Kieber-Emmons et al. Frontiers in oncology. 2012
6 Ab2 is a surrogate of Ag
7 Anti-idiotypic antibodies in autoimmune diseases
8 Background data IFA pattern [%]* Convenien ce control Female Osteoarthr itis control Female Benign breast disease Ductal carcinoma in situ Invasive carcinoma Homogeneous Speckled Anti-nucleolar Anti-centromere Anti-centrosome Antimitochondrial Multiple nuclear dots Cytoskeletal Mixed pattern Other
9 Background data IFA pattern [%]* Convenien ce control Female Osteoarthr itis control Female Benign breast disease Ductal carcinoma in situ Invasive carcinoma Homogeneous Speckled Anti-nucleolar Anti-centromere Anti-centrosome Antimitochondrial Multiple nuclear dots Cytoskeletal Mixed pattern Other
10
11 Significance of autoantibodies in BC Antigens: a plethora of BC tumor-associated antigens [TAAs] Expression of a B-cell and T-cell-orchestrated anti-cancer immune response Potential diagnostic and prognostic biomarkers of BC Identification of molecular targets involved in carcinogenesis
12 Objectives Characterize and identify the specificity of the autoantibodies detected by immunofluorescence To assess the relative contribution of cancer cells versus cancer tissue
13 Methods Immunoscreening of 2 cdna libraries of breast cancer autoantigens with BC sera mrna from invasive BC tissue mrna from isolated 8 BC cell lines Autoantigen microarray Sequence analyses and homology searches
14 Results Cloning of autoantibodies recognizing multiple idiotypes and allotypes of immunoglobulins
15 Results Cloning of autoantibodies recognizing multiple idiotypes and allotypes of immunoglobulins Targets: IgG1 constant and variable region Lambda light chain variable region Heavy chain constant and variable region
16 Results Cloning of autoantibodies recognizing multiple idiotypes and allotypes of immunoglobulins Targets: IgG1 constant and variable region Lambda light chain variable region Heavy chain constant and variable region No anti-idiotype immunoglobulins were cloned by immunoscreening the cdna library from established BC cell lines
17 Idiotypes identified (anti-anti-v region of IgG1) Protein Function TNF-alpha IL-13 IL-17a Peptide/ MHC complex HLA-A1 TARP HEDGEHOG ERBB2 NOTCH EGFR VEGF CD18 Collagen VII Pro-Inflammatory cytokine Pro-Inflammatory cytokine Pro-Inflammatory cytokine Immune surveillance TSA Signaling pathway Signaling pathway Signaling pathway Receptor-signaling pathway Cytokine-Angiogenic Integrin-cell adhesion-cell surface signaling Basement membrane-tumor Invasion
18 Idiotypes identified (anti-anti-v region of IgG1) Protein Function TNF-alpha IL-13 IL-17a Peptide/ MHC complex HLA-A1 TARP HEDGEHOG ERBB2 NOTCH EGFR VEGF CD18 Collagen VII Pro-Inflammatory cytokine Pro-Inflammatory cytokine Pro-Inflammatory cytokine Immune surveillance TSA Signaling pathway Signaling pathway Signaling pathway Receptor-signaling pathway Cytokine-Angiogenic Integrin-cell adhesion-cell surface signaling Basement membrane-tumor Invasion
19 Idiotypes identified (anti-anti-v region of IgG1) Protein Function TNF-alpha IL-13 IL-17a Peptide/ MHC complex HLA-A1 TARP HEDGEHOG ERBB2 NOTCH EGFR VEGF CD18 Collagen VII Pro-Inflammatory cytokine Pro-Inflammatory cytokine Pro-Inflammatory cytokine Immune surveillance TSA Signaling pathway Signaling pathway Signaling pathway Receptor-signaling pathway Cytokine-Angiogenic Integrin-cell adhesion-cell surface signaling Basement membrane-tumor Invasion
20 Conclusions Antigen-driven anti-autoantibody synthesis and maturation takes place in breast tumor tissue Antibodies, when performing the function of autoantigens, elicit an idiotypic response that could be a marker of cancer Idiotypes identifed may be involved in cancer pathogenesis
21 Conclusions Autoimmunity driven by TAAs Inflammation Breast carcinogenesis
22 What s next? Panel of biomarkers for early breast cancer Targeted therapy in breast cancer
23 Acknowledgements Collaborators Lawrence Grossman Rooshan Arshad Leonard Lipovich Michael Long Azadeh Stark Carol L. Peebles Félix Fernández Madrid Participating institutions Wayne State University Karmanos Cancer Institute, Detroit, MI INOVA, San Diego, CA Geisinger Health System, Danville, PA Henry Ford Health System, Detroit, MI
Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis
Fernández Madrid et al. BMC Cancer (2015) 15:407 DOI 10.1186/s12885-015-1385-8 RESEARCH ARTICLE Open Access Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis
More informationMon, Wed, Fri 11:00 AM-12:00 PM. Owen, Judy, Jenni Punt, and Sharon Stranford Kuby-Immunology, 7th. Edition. W.H. Freeman and Co., New York.
Course Title: Course Number: Immunology Biol-341/541 Semester: Fall 2013 Location: HS 268 Time: Instructor: 8:00-9:30 AM Tue/Thur Dr. Colleen M. McDermott Office: Nursing Ed 101 (424-1217) E-mail*: mcdermot@uwosh.edu
More informationBachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES
Bachelor of Chinese Medicine (2002 2003) BCM II Dr. EYT Chan February 6, 2003 9:30 am 1:00 pm Rm 134 UPB AUTOIMMUNE DISEASES 1. Introduction Diseases may be the consequence of an aberrant immune response,
More informationUniversity of Pretoria
University of Pretoria Serodiagnostic Procedures Performed in the Department of Immunology Dr Pieter WA Meyer 1.Autoimmune Diseases Automated Anti-nuclear antibodies Anti-gliadin/ tissue transglutaminase
More informationDISCLOSURE. Relevant relationships with commercial entities none. Potential for conflicts of interest within this presentation none
AUTOIMMUNITY DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and mitigate potential bias N/A MODULE
More informationThey determine if there will be an immune response. Determine functions associated with immune response, but not specific to Ag.
Appendices A They determine if there will be an immune response. Antigen receptor genes in T cells (TCR) and B cell (Ig) Determine functions associated with immune response, but not specific to Ag. MHC
More informationAllergy and Immunology Review Corner: Chapter 19 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.
Allergy and Immunology Review Corner: Chapter 19 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Chapter 19: Tolerance, Autoimmunity, and Autoinflammation Prepared
More informationWhat will we discuss today?
Autoimmune diseases What will we discuss today? Introduction to autoimmune diseases Some examples Introduction to autoimmune diseases Chronic Sometimes relapsing Progressive damage Epitope spreading more
More informationInternational Society of Breast Pathology. Immune Targeting in Breast Cancer. USCAP 2017 Annual Meeting
International Society of Breast Pathology USCAP 2017 Annual Meeting Immune Targeting in Breast Cancer Ashley Cimino-Mathews, MD Assistant Professor of Pathology and Oncology The Johns Hopkins Hospital
More informationIDENTIFICATION OF BIOMARKERS FOR EARLY DIAGNOSIS OF BREAST CANCER"
IDENTIFICATION OF BIOMARKERS FOR EARLY DIAGNOSIS OF BREAST CANCER" Edmond Marzbani, MD December 2, 2008 Early diagnosis of cancer Many solid tumors are potentially curable if diagnosed at an early stage
More informationMHC class I MHC class II Structure of MHC antigens:
MHC class I MHC class II Structure of MHC antigens: MHC class I antigens consist of a transmembrane heavy chain (α chain) that is non-covalently associated with β2- microglobulin. Membrane proximal domain
More informationThird line of Defense
Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)
More informationMOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism
MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism SCHMAIEL SHIRDEL CONTENT 2 Introduction Autoimmune diseases Classification Involved components Autoimmune
More informationClinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18
Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Thyroid Peroxidase (TPO) Antibody 5.0 IU/mL [0.0-9.0] 18-289-900139 16-Oct-18 Complement Component 3 50 mg/dl 18-289-900139
More informationClinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18
Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Rheumatoid Factor
More informationImmunological Tolerance
Immunological Tolerance Introduction Definition: Unresponsiveness to an antigen that is induced by exposure to that antigen Tolerogen = tolerogenic antigen = antigen that induces tolerance Important for
More informationDevelopment of B and T lymphocytes
Development of B and T lymphocytes What will we discuss today? B-cell development T-cell development B- cell development overview Stem cell In periphery Pro-B cell Pre-B cell Immature B cell Mature B cell
More informationAutoantibodies panel ANA
Autoantibodies panel ANA Anti-nuclear antibodies, ANA screening General: Anti-nuclear antibodies (ANA) contain all kinds of autoantibodies against nuclear antigens. Their targets are cell components in
More informationAdvances in Laboratory Testing for Rheumatic Diseases Updates in Testing for Rheumatic Diseases. The ABIM s view of rheumatologic lab testing
The black hole of medical knowledge: An internist s view of rheumatologic lab tests Advances in Laboratory Testing for Rheumatic Diseases 2010 Jonathan Graf, M.D. Assistant Clinical Professor of Medicine
More informationThird line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!
Topic 8 Specific Immunity (adaptive) (18) Topics - 3 rd Line of Defense - B cells - T cells - Specific Immunities 1 3 rd Line = Prophylaxis via Immunization! (a) A painting of Edward Jenner depicts a cow
More informationInternational Journal of Pharma and Bio Sciences
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 A COMPARATIVE STUDY OF ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) WITH IMMUNOFLUORESCENCE ASSAY (IFA) FOR THE
More informationLecture 2. Immunoglobulin
Lecture 2 Immunoglobulin Objectives; Define secretary IgA Describe structure & functions of IgM Compare the antigenic receptor of B lymphocyte Assess the role of IgE in Atopy Distinguish between Isotype,
More informationLecture 2. Immunoglobulin
Lecture 2 Immunoglobulin Objectives; To study the secretary IgA To know the structure & functions of IgM The antigenic receptor of B lymphocyte The role of IgE in Atopy The difference between Isotype,
More informationEnhancing the Clinical Activity of HER2/neu Specific T Cells. William Gwin, MD Internal Medicine, Resident University of Washington
Enhancing the Clinical Activity of HER2/neu Specific T Cells William Gwin, MD Internal Medicine, Resident University of Washington Immunotherapy and Cancer Cancer vaccines were originally used in melanoma
More information3D in vitro modelling using material from the Breast Cancer Now Tissue Bank
@QMBCI bartscancerinstitute 3D in vitro modelling using material from the Breast Cancer Now Tissue Bank Richard Grose Barts Cancer Institute Ed Carter Normal Breast Architecture Calponin / CK8 Myoepithelial
More informationVaccine Therapy for Cancer
Vaccine Therapy for Cancer Lawrence N Shulman, MD Chief Medical Officer Senior Vice President for Medical Affairs Chief, Division of General Oncology Dana-Farber Cancer Institute Disclosures for Lawrence
More informationMAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt.
MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt. AUTOIMMUNE DISEASE RA SLE VASCULITIS RELAPSING POLYCHONDRITIS SS DM/PM SJOGREN S SYNDROME RHEUMATOID ARTHRITIS Classically immune mediated
More informationPhenotypic analysis of primary colorectal cancer to inform the management of metastatic disease
Phenotypic analysis of primary colorectal cancer to inform the management of metastatic disease Paul Sutton CR(UK) Clinical Research Training Fellow Chester Colorectal Research Disclosures Holder of CR(UK)
More informationCONTENTS. About the Authors, xv Contributors, xvi Preface and Acknowiedgments, xvii How to Use Your Textbook, xix About the Companion Website, xxiii
Coico, Richard Immunology 2015 About the Authors, xv Contributors, xvi Preface and Acknowiedgments, xvii How to Use Your Textbook, xix About the Companion Website, xxiii 1 OVERVIEW OF THE IMMUNE SYSTEM,
More informationClinical Laboratory. [None
Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Double-Stranded DNA (dsdna) Ab IgG ELISA Detected * [None 18-289-900151 Detected] Double-Stranded DNA (dsdna) Ab IgG
More informationThe Generation of Specific Immunity
The Generation of Specific Immunity Antibody structure! Antibodies classified by specificity (antigen, binding site) and class (general structure, function)! Differences in variable regions produce different
More informationDiseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.
Diseases of Immunity 2017 CL Davis General Pathology Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc. Autoimmunity Reflects a loss of immunologic tolerance Mechanisms Auto-antibodies
More informationThe Power of the ANA. April 2018 Emily Littlejohn, DO MPH
Emergent Rheumatologic Diseases and Disorders for Primary Care. The Power of the ANA April 2018 Emily Littlejohn, DO MPH Question 1: the ANA test is: A) A screening test with high specificity to diagnose
More informationSCIENCE WEBINAR. Autoantibody Biomarkers for Cancer and Autoimmune Disease. Eng M Tan, M. D. The Scripps Research Institute La Jolla, California
SCIENCE WEBINAR Autoantibody Biomarkers for Cancer and Autoimmune Disease Eng M Tan, M. D. The Scripps Research Institute La Jolla, California Systemic Lupus Erythematosus The Prototype Autoimmune Disease
More informationAlessandra Franco MD PhD UCSD School of Medicine Department of Pediatrics Division of Allergy Immunology and Rheumatology
Immunodominant peptides derived from the heavy constant region of IgG1 stimulate natural regulatory T cells: identification of pan- HLA binders for clinical translation Alessandra Franco MD PhD UCSD School
More informationImmune surveillance hypothesis (Macfarlane Burnet, 1950s)
TUMOR-IMMUNITÄT A.K. Abbas, A.H. Lichtman, S. Pillai (6th edition, 2007) Cellular and Molecular Immunology Saunders Elsevier Chapter 17, immunity to tumors Immune surveillance hypothesis (Macfarlane Burnet,
More informationResearch Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
SAGE-Hindawi Access to Research International Breast Cancer Volume 20, Article ID 47957, 4 pages doi:0.406/20/47957 Research Article Stromal Expression of CD0 in Invasive Breast Carcinoma and Its Correlation
More informationChapter 23 Immunity Exam Study Questions
Chapter 23 Immunity Exam Study Questions 1. Define 1) Immunity 2) Neutrophils 3) Macrophage 4) Epitopes 5) Interferon 6) Complement system 7) Histamine 8) Mast cells 9) Antigen 10) Antigens receptors 11)
More informationGeisinger Clinic Annual Progress Report: 2011 Formula Grant
Geisinger Clinic Annual Progress Report: 2011 Formula Grant Reporting Period July 1, 2012 June 30, 2013 Formula Grant Overview The Geisinger Clinic received $75,516 in formula funds for the grant award
More informationAdvances in Autoantibody Testing & Clinical Applications
Advances in Autoantibody Testing & Clinical Applications Marvin J. Fritzler PhD MD Member: IUIS-WHO-AF-CDC Serology Committee Director: Advanced Diagnostics Laboratory University of Calgary Introduction
More informationTolerance 2. Regulatory T cells; why tolerance fails. FOCiS. Lecture outline. Regulatory T cells. Regulatory T cells: functions and clinical relevance
1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails
More informationCELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.
!! www.clutchprep.com CONCEPT: OVERVIEW OF HOST DEFENSES The human body contains three lines of against infectious agents (pathogens) 1. Mechanical and chemical boundaries (part of the innate immune system)
More informationSupplementary data Table S3. GO terms, pathways and networks enriched among the significantly correlating genes using Tox-Profiler
Supplementary data Table S3. GO terms, pathways and networks enriched among the significantly correlating genes using Tox-Profiler DR CALUX Boys Girls Database Systemic lupus erythematosus 4.4 0.0021 6.7
More informationTest Name Results Units Bio. Ref. Interval
135091662 Age 45 Years Gender Male 29/8/2017 120000AM 29/8/2017 100215AM 29/8/2017 110825AM Ref By Final RHEUMATOID AUTOIMMUNE COMREHENSIVE ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), SERUM ----- 20-60
More informationINTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE
INTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE Laboratory tests are an important adjunct in the clinical diagnosis of rheumatic diseases and are sometimes helpful in monitoring the activity of
More informationBALANCE BETWEEN ESTROGENS AND PROINFLAMMATORY CYTOKINES REGULATES CHEMOKINE PRODUCTION INVOLVED IN THYMIC GERMINAL CENTER FORMATION
BALANCE BETWEEN ESTROGE AND PROINFLAMMATORY CYTOKINES REGULATES CHEMOKINE PRODUCTION INVOLVED IN THYMIC GERMINAL CENTER FORMATION Nadine Dragin 1, 2, 3,, Patrice Nancy 4, José Villegas 2, 3, 5, Régine
More informationMSc CANCER CELL AND MOLECULAR BIOLOGY (2008/9)
Faculty of Medicine and Biological Sciences Department of Biochemistry MSc CANCER CELL AND MOLECULAR BIOLOGY (2008/9) COURSE AIMS AND STRUCTURE Background The MSc in Cancer Cell and Molecular Biology is
More informationLYMPHOCYTES & IMMUNOGLOBULINS. Dr Mere Kende, Lecturer SMHS
LYMPHOCYTES & IMMUNOGLOBULINS Dr Mere Kende, Lecturer SMHS Immunity Immune- protection against dangers of non-self/invader eg organism 3 components of immune system 1 st line: skin/mucosa/cilia/hair/saliva/fatty
More informationScreening for novel oncology biomarker panels using both DNA and protein microarrays. John Anson, PhD VP Biomarker Discovery
Screening for novel oncology biomarker panels using both DNA and protein microarrays John Anson, PhD VP Biomarker Discovery Outline of presentation Introduction to OGT and our approach to biomarker studies
More informationIBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease
IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease Inflammatory Bowel Disease Experts in Autoimmunity Inova Diagnostics offers a complete array of methods to aid in the diagnosis
More informationMolecular and Cellular Basis of Immune Protection of Mucosal Surfaces
Molecular and Cellular Basis of Immune Protection of Mucosal Surfaces Department of Biologic & Materials Sciences School of Dentistry University of Michigan Ann Arbor, Michigan 48109-1078 1 Image quality
More informationEffector T Cells and
1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New
More informationBudsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital
Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital Outline What is ANA? How to detect ANA? Clinical application Common autoantibody in ANA diseases Outline What is ANA? How to detect ANA? Clinical
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationMolecular Methods in the Diagnosis and Prognostication of Melanoma: Pros & Cons
Molecular Methods in the Diagnosis and Prognostication of Melanoma: Pros & Cons Ben J. Friedman, MD Senior Staff Physician Department of Dermatology Department of Pathology and Laboratory Medicine Henry
More informationMicr-6005, Current Concepts of Immunology (Rutgers course number: 16:681:543) Spring 2009 Semester
Micr-6005, Current Concepts of Immunology (Rutgers course number: 16:681:543) (3 Credits) Spring 2009 Semester Course Director: (732-235-4501, ) Please note that this course is offered once every 2 years.
More informationAUTOIMMUNITY CLINICAL CORRELATES
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More informationAUTOIMMUNITY TOLERANCE TO SELF
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More informationThe Major Histocompatibility Complex (MHC)
The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens
More informationAccuSet Autoimmune Performance Panel
PACKAGE INSERT 0840-0001 INTENDED USE The 0840-0001 is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot autoimmune related test
More informationUse of Serological markers for evaluation of patients with Rheumatoid arthritis
ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 61-66 http://www.ijcmas.com Original Research Article Use of Serological markers for evaluation of patients with Rheumatoid arthritis G. Sucilathangam*, G.
More informationPD-L1 Analyte Control DR
Quality in Control PD-L1 Analyte Control DR PD-L1_PI_v2 Product Codes: HCL019, HCL020 and HCL021 Contents PD-L1 Analyte Control DR 2 What is PD-L1? 3 The Role of PD-L1 in Cancer 3 PD-L1 Assessment 4 PD-L1
More informationKey Publications For EarlyCDT Liver for lesions
Key Publications For EarlyCDT Liver for lesions Development Studies Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma. Middleton CH, Irving W, Robertson JFR, et al. PLoS ONE.
More informationBasic Immunology. Immunological tolerance. Cellular and molecular mechanisms of the immunological tolerance. Lecture 23 rd
Basic Immunology Lecture 23 rd Immunological tolerance Cellular and molecular mechanisms of the immunological tolerance Tolerated skin grafts on MHC (H2) identical mice TOLERANCE & AUTOIMMUNITY Upon encountering
More informationThe T cell receptor for MHC-associated peptide antigens
1 The T cell receptor for MHC-associated peptide antigens T lymphocytes have a dual specificity: they recognize polymporphic residues of self MHC molecules, and they also recognize residues of peptide
More informationAndrea s SI Session PCB Practice Test Test 3
Practice Test Test 3 READ BEFORE STARTING PRACTICE TEST: Remember to please use this practice test as a tool to measure your knowledge, and DO NOT use it as your only tool to study for the test, since
More informationTumors arise from accumulated genetic mutations. Tumor Immunology (Cancer)
Tumor Immunology (Cancer) Tumors arise from accumulated genetic mutations Robert Beatty MCB150 Mutations Usually have >6 mutations in both activation/growth factors and tumor suppressor genes. Types of
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091593 Age 25 Years Gender Male 30/8/2017 91600AM 30/8/2017 93946AM 31/8/2017 84826AM Ref By Final COLLAGEN DISEASES ANTIBODY ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF),
More informationA Multiplex Autoantibody Panel for Early Detection of Autoimmune Disease Activity
Open Journal of Rheumatology and Autoimmune Diseases, 2018, 8, 43-52 http://www.scirp.org/journal/ojra ISSN Online: 2164-005X ISSN Print: 2163-9914 A Multiplex Autoantibody Panel for Early Detection of
More informationAssays. New. New. Combinations. Possibilities. Patents: EP , AU
Assays Patents: EP 2362222, AU 2011217190 New Combinations New Possibilities Technology Classical Handling of Autoimmune Diagnostics 2-Step Diagnostics 1 st Screening 2 nd Confirmation Cell based IFA ELISA
More informationImmunology lecture: 14. Cytokines: Main source: Fibroblast, but actually it can be produced by other types of cells
Immunology lecture: 14 Cytokines: 1)Interferons"IFN" : 2 types Type 1 : IFN-Alpha : Main source: Macrophages IFN-Beta: Main source: Fibroblast, but actually it can be produced by other types of cells **There
More informationCANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University
CANCER IMMUNOPATHOLOGY Eryati Darwin Faculty of Medicine Andalas University Padang 18 Mei 2013 INTRODUCTION Tumor: cells that continue to replicate, fail to differentiate into specialized cells, and become
More informationPreface and Acknowledgments Preface and Acknowledgments to the Third Edition Preface to the Second Edition Preface to the First Edition
Preface and Acknowledgments p. xxi Preface and Acknowledgments to the Third Edition p. xxiii Preface to the Second Edition p. xxv Preface to the First Edition p. xxvii Acknowledgments to the First and
More informationRequirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope
+ T cell MHC/self-peptide MHC/Vβ Induction of + T H 1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetes APC Activated autoreactive +
More informationAutoimmune diseases, their pathogenic mechanisms and treatment of unwanted immune responses (Janeway s Immunobiology)
Autoimmune diseases, their pathogenic mechanisms and treatment of unwanted immune responses (Janeway s Immunobiology) Picture source: https://www.klini kum.uniheidelberg.de/fil eadmin/pressest elle/pm_neu/20
More informationNew Drugs for Uveitis. Medical Eye Unit St Thomas Hospital
New Drugs for Uveitis Miles Stanford Medical Eye Unit St Thomas Hospital x Epithelium x x Antigen Y Y Y Y IgG m cd4 IL-2 Y m + IL-12 Cytotoxic T B pmn Ig s PG s. LTB4 O - IL-6 TNFα IFNγγ IL-2 Th1 IL-10
More informationClinical Translation of a Mammaglobin A DNA Vaccine for Breast Cancer Therapy
Clinical Translation of a Mammaglobin A DNA Vaccine for Breast Cancer Therapy William E. Gillanders, M.D. Recombinant DNA Advisory Committee December 14, 25 Overview This is a phase I dose ranging vaccine
More informationRadiobiology of high dose per fraction
Radiobiology of high dose per fraction Michael Joiner Wayne State University Radiation Oncology Detroit, Michigan joinerm@wayne.edu AAPM 2014 Historically Research focused on clinically relevant doses
More informationB cell activation and antibody production. Abul K. Abbas UCSF
1 B cell activation and antibody production Abul K. Abbas UCSF 2 Lecture outline B cell activation; the role of helper T cells in antibody production Therapeutic targeting of B cells 3 Principles of humoral
More informationBases for Immunotherapy in Multiple Myeloma
Bases for Immunotherapy in Multiple Myeloma Paola Neri, MD, PhD Associate Professor of Medicine University of Calgary, Arnie Charbonneau Cancer Institute Disclosures Paola Neri MD, PhD Grants/research
More informationB cell development in the bone marrow.
development in the bone. s develop from multipotent haematopoietic stem s in the bone that produce lymphoid progenitors which in turn generate s. s with a unique antibody specificity develop by initial
More informationIntegrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1
Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1 CHRISTOPH RADER, 2 MIKHAIL POPKOV, JOHN A. NEVES, AND CARLOS F. BARBAS III 2 Department of Molecular Biology and The
More informationAssociation of anti-mcv autoantibodies with SLE (Systemic Lupus Erythematosus) overlapping with various syndromes
International Journal of Medicine and Medical Sciences Vol. () pp. 21-214, June 211 Available online http://www.academicjournals.org/ijmms ISSN 2-972 211 Academic Journals Full Length Research Paper Association
More informationInteraction between the immune system and tumor
Tumor immunology Interaction between the immune system and tumor elimination (immune system attempts to kill cancer cells and inhibits tumor growth) balance (between elimination and growth of tumor cells)
More informationComparative Effectiveness Research and Shared Decision Making
Comparative Effectiveness Research and Shared Decision Making The Third National Comparative Effectiveness Summit October14, 2011 Michael J. Barry, MD Foundation President Mission Foundation Mission The
More informationAutoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens
Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly
More informationManuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis
Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis Vincent Laufer Rheumatology JC October 17 Disclosures NIH 2
More informationIg light chain rearrangement: Rescue pathway
B Cell Development Ig light chain rearrangement: Rescue pathway There is only a 1:3 chance of the join between the V and J region being in frame Vk Jk Ck Non-productive Rearrangement Light chain has a
More informationCOURSE: Medical Microbiology, MBIM 650/720 - Fall TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12
COURSE: Medical Microbiology, MBIM 650/720 - Fall 2008 TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12 FACULTY: Dr. Mayer Office: Bldg. #1, Rm B32 Phone: 733-3281 Email: MAYER@MED.SC.EDU
More informationNegative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α
Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α Mahnaz Janghorban, PhD Dr. Rosalie Sears lab 2/8/2015 Zanjan University Content 1. Background (keywords: c-myc, PP2A,
More informationImmunology Lesson plan for international medical students
Immunology Lesson plan for international medical students Kermanshah University of medical sciences (KUMS) international affairs School of medicine Department of Immunology Lecturers: Dr. Ali Gorgin Karaji
More informationFour main classes of human tumor antigens recognized by T cells: 1- "Cancer-testis" antigens: non-mutated genes reactivated in neoplastic cells, but
Tumor antigens Andrea Anichini Human Tumors Immunobiology Unit, Dept. of Experimental Oncology and Molecular Medicine Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Timeline of the discovery of
More informationHow T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do? Monoclonal antibody approach
How T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do By the early 1980s, much about T cell function was known, but the receptor genes had not been identified
More informationA second type of TCR TCR: An αβ heterodimer
How s recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do By the early 1980s, much about function was known, but the receptor genes had not been identified Recall
More informationREACTOME: Nonsense Mediated Decay (NMD) REACTOME:72764 Eukaryotic Translation Termination. REACTOME:72737 Cap dependent Translation Initiation
A REACTOME:975957 Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) REACTOME:975956 Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) REACTOME:927802
More informationImmunology for the Rheumatologist
Immunology for the Rheumatologist Rheumatologists frequently deal with the immune system gone awry, rarely studying normal immunology. This program is an overview and discussion of the function of the
More informationPhysiology Unit 3. ADAPTIVE IMMUNITY The Specific Immune Response
Physiology Unit 3 ADAPTIVE IMMUNITY The Specific Immune Response In Physiology Today The Adaptive Arm of the Immune System Specific Immune Response Internal defense against a specific pathogen Acquired
More informationDiseases-causing agents, pathogens, can produce infections within the body.
BIO 212: ANATOMY & PHYSIOLOGY II 1 CHAPTER 16 Lecture: Dr. Lawrence G. Altman www.lawrencegaltman.com Some illustrations are courtesy of McGraw-Hill. LYMPHATIC and IMMUNE Systems Body Defenses Against
More information[AUTOIMMUNITY] July 14, 2013
This sheet includes only the extra notes. Slide 5,6: [AUTOIMMUNITY] July 14, 2013 Autoimmunity is the condition or case where the immune system is activated by self antigensand when the immune system no
More information